Voxelotor, which can help reduce need for blood transfusions, is administered as a daily tablet
A new treatment for sickle cell disease has been recommended by the health watchdog in a move described as life-changing for people living with the condition in England.
The drug, Voxelotor, has been recommended for use on the NHS in England by the National Institute for Health and Care Excellence (Nice) in people with the disease who are aged 12 and over.
